Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for GABA-T inhibitor precursor via lactam rearrangement offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN114716375A details a novel chiral resolution process achieving >99.9% optical purity for Mivacurium intermediates, ensuring superior safety and scalable manufacturing.
Patent CN110358752A reveals enzymatic route for high-purity Brivaracetam intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel resolution method for high-purity chiral pyrazolo isoquinoline. Cost-effective scalable process for PARP inhibitor intermediates ensuring supply chain reliability.
Patent CN102660625A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102796065A details a novel resolution and cyclization route for S-escitalopram, offering superior optical purity and simplified manufacturing for global pharmaceutical supply chains.
Advanced synthesis of stable Clopidogrel Hydrogen Sulfate Form II via optimized solvent strategy. High purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN105200076A reveals high-purity gamma-lactam production. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN101142211B details a robust resolution process for cis-oxathiolane cytosine derivatives, offering significant cost reduction and supply chain reliability for antiviral API manufacturing.
Patent CN107827890A reveals dynamic kinetic resolution for high-purity chiral purine acyclic nucleosides offering supply chain reliability and cost reduction.
Advanced patent CN104151352A details high-purity Sofosbuvir intermediate preparation via dynamic kinetic resolution ensuring supply chain reliability and cost efficiency.
Patent CN114591219A details a water-based resolution process for S-3-aminopiperidine dihydrochloride, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN111194304B details an enzymatic method for chiral bridged rings. Offers high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Novel patent CN102858759B enables high-purity Nebivolol production without HPLC, offering significant supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Novel resolution process using L-tartaric acid improves purity >99.8% and reduces costs for reliable pharma intermediate suppliers.
Patent CN102399166B enables high-purity THPBs synthesis. Reduces cost and improves supply chain reliability for neurological drug intermediates.
Novel five-step route avoids hazardous HMPA and cryogenic conditions. Delivers high purity pharmaceutical intermediates with scalable industrial production capabilities.
Patent CN103012264A details a robust resolution method for (R)-3-amino-hexahydro-1H-azepane using tartaric acid, ensuring superior optical purity for ophthalmic antibiotics.
Patent CN109593055B details a scalable resolution method for Brivaracetam isomer (2S, 4S), eliminating chromatography for cost-effective pharmaceutical intermediate manufacturing.
Patent CN103224467A details a cost-effective resolution method for (-)-Huperzine A, achieving >99.5% purity and significantly reducing manufacturing costs for pharmaceutical applications.